Author:
Smith Ian,Robertson John,Kilburn Lucy,Wilcox Maggie,Evans Abigail,Holcombe Chris,Horgan Kieran,Kirwan Cliona,Mallon Elizabeth,Sibbering Mark,Skene Anthony,Vidya Raghavan,Cheang Maggie,Banerji Jane,Morden James,Sidhu Kally,Dodson Andrew,Bliss Judith M,Dowsett Mitch
Reference24 articles.
1. Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival;Dowsett;Clin Cancer Res,2005
2. Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status;Ellis;Cancer Res,2003
3. Presence of a growth-stimulating factor in serum following primary tumor removal in mice;Fisher;Cancer Res,1989
4. Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice;Fisher;Cancer Res,1989
5. A prognostic index in primary breast cancer;Haybittle;Br J Cancer,1982